Literature DB >> 11259995

The pharmacokinetics of etanercept in patients with heart failure.

O Soran, A M Feldman, V M Schneider, R Hanna, D L Mann, J M Korth-Bradley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11259995      PMCID： PMC2014439          DOI： 10.1111/j.1365-2125.2001.01279.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  The pharmacokinetics of etanercept in healthy volunteers.

Authors:  J M Korth-Bradley; A S Rubin; R K Hanna; D K Simcoe; M E Lebsack
Journal:  Ann Pharmacother       Date:  2000-02       Impact factor: 3.154

2.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

Review 3.  Clinical pharmacokinetics in heart failure. An updated review.

Authors:  F V Shammas; K Dickstein
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

Review 4.  Etanercept: a review of its use in rheumatoid arthritis.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 5.  Drug-patient interactions and their relevance in the treatment of heart failure.

Authors:  D Johnston; D Duffin
Journal:  Am J Cardiol       Date:  1992-10-08       Impact factor: 2.778

6.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G Torre-Amione; S Kapadia; C Benedict; H Oral; J B Young; D L Mann
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094
  6 in total
  4 in total

1.  Effect of the soluble TNF-antagonist etanercept on tumor necrosis factor bioactivity and stability.

Authors:  Douglas L Mann; Biykem Bozkurt; Guillermo Torre-Amione; Ozlem Z Soran; Natarajan Sivasubramanian
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

Review 2.  Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Authors:  Christine R Culy; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously).

Authors:  Ryuichi Ogawa; Joan M Stachnik; Hirotoshi Echizen
Journal:  Clin Pharmacokinet       Date:  2013-03       Impact factor: 6.447

Review 4.  Etanercept: a review of its use in the management of rheumatoid arthritis.

Authors:  Sohita Dhillon; Katherine A Lyseng-Williamson; Lesley J Scott
Journal:  Drugs       Date:  2007       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.